Merck vows to press ahead with Vioxx defence
9th Sep 2005, 23:19 GMT
NEW YORK (Reuters) - On the eve of a second court battle over its arthritis drug Vioxx, Merck & Co. MRK.N said on Friday it does not plan to enter into any global settlement of the thousands of Vioxx lawsuits it faces and is focussed on "defending these cases one at a time."
Latest news from Reuters: Business:
- BA ups stakes in bed wars
- AMEC spurns bid approach from private equity team
- Resolution eyes options for future
- Stricter savings-club rules seen after Farepak
- Airbus to outsource 1.84 bln pounds of new work
- Supermarkets rapped on food packaging
- British defence ministry seeks delay in KBR IPO
- Dell buys ACS to expand UK technology consulting
- Anglo American eyes China coal-to-energy project
- Barrick in approach for European Goldfields - paper